Dusseldorf - Delayed Quote EUR
MediPharm Labs Corp (MLZ.DU)
0.0444
-0.0026
(-5.53%)
As of 9:32:30 AM GMT+2. Market Open.
Loading Chart for MLZ.DU
- Previous Close
0.0470 - Open
0.0446 - Bid 0.0444 x --
- Ask 0.0518 x --
- Day's Range
0.0444 - 0.0446 - 52 Week Range
0.0360 - 0.0688 - Volume
0 - Avg. Volume
12 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 12, 2025 - Aug 18, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: MLZ.DU
View MorePerformance Overview: MLZ.DU
Trailing total returns as of 5/29/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
MLZ.DU
12.12%
S&P/TSX Composite index (^GSPTSE)
6.75%
1-Year Return
MLZ.DU
12.94%
S&P/TSX Composite index (^GSPTSE)
20.03%
3-Year Return
MLZ.DU
12.60%
S&P/TSX Composite index (^GSPTSE)
26.68%
5-Year Return
MLZ.DU
96.39%
S&P/TSX Composite index (^GSPTSE)
73.00%
Compare To: MLZ.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.0444
-5.53%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.9350
+1.65%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.1800
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.5400
+2.86%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4045
+3.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
3.5340
-0.56%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.1970
0.00%
Mkt Cap EUR 68.674M
Industry Drug Manufacturers—Specialty & Generic
4.9350
+2.81%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4031
-1.01%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4055
+1.99%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: MLZ.DU
View MoreValuation Measures
As of 5/28/2025
Market Cap
19.88M
Enterprise Value
14.57M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.70
Price/Book (mrq)
0.71
Enterprise Value/Revenue
0.53
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--